aliskiren 150 MG Oral Tablet

RxCUI: 1011736
RxNorm name: aliskiren 150 MG Oral Tablet
Display name: Aliskiren (Oral Pill)
Full name: aliskiren 150 MG Oral Tablet
Term type: SCD
Status: Active
Strength: 150 mg
Dose form: Tab
Route: Oral Pill
Updated: 2026-10-26 03:52:46

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 102010
Active start: 102010
Multiple ingredient: NO
Branded: NO

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
aliskiren hemifumarate	150 MG / 1 EACH	aliskiren	aliskiren

Dose Form Concepts#

Dose form, RxCUI table
Dose form	RxCUI
Oral Tablet	317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
aliskiren	325646

Source Vocabulary Codes#

Code type, Values, Count table
Code type	Values	Count	Category
PRESCRIBABLE	Y	1	ATTRIBUTES
RXNAV_STR	aliskiren 150 MG Oral Tablet	1	NAMES
RxNorm Name	aliskiren 150 MG Oral Tablet	1	NAMES
RxNorm Synonym	aliskiren (as aliskiren fumarate) 150 MG Oral Tablet	1	NAMES
TTY	SCD	1	ATTRIBUTES
SPL_SET_ID	2 linked values 41c0e5e0-eb26-4d9e-bcd2-d0f2cc8fc6db f3fd2503-25ef-4660-a29a-f62c491e28fb	2	CODES
RxCUI	1011736	1	CODES
MMSL_CODE	2 linked values BD19232 CD19232	2	CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDC	Product NDC	Name	Labeler	Application
49884-424-11	49884-424	ALISKIREN ALISKIREN	Par Health USA, LLC	ANDA206665
66993-141-30	66993-141	Aliskiren aliskiren hemifumarate	Prasco Laboratories	NDA021985

Drugs@FDA Applications#

Application, NDC, Name table
Application	NDC	Name	Marketing category	Labeler
ANDA206665	49884-424	ALISKIREN ALISKIREN	ANDA	Par Health USA, LLC
NDA021985	66993-141	Aliskiren aliskiren hemifumarate	NDA AUTHORIZED GENERIC	Prasco Laboratories

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 12 matching rows.

NDC11, Source, Active table
NDC11	Source	Active
49884042411	rxnav_ndcs	yes
66993014130	rxnav_ndcs	yes
00078048515	rxnav_historical_indirect
00078048534	rxnav_historical_indirect
00078048535	rxnav_historical_indirect
12280040030	rxnav_historical_indirect
17088006601	rxnav_historical_indirect
35356013330	rxnav_historical_indirect
51129427001	rxnav_historical_indirect
51129427002	rxnav_historical_indirect
54868577200	rxnav_historical_indirect
66828002101	rxnav_historical_indirect

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Tekturna	ALISKIREN HEMIFUMARATE	LXO US Inc.	3dd61fa5-1620-4ebf-bbdb-ede29b92fce2	2024-03-07	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1011736
Aliskiren	ALISKIREN HEMIFUMARATE	Prasco Laboratories	41c0e5e0-eb26-4d9e-bcd2-d0f2cc8fc6db	2023-05-01	Boxed warning, Warnings, Adverse reactions	Exact identifier ndc (package): 66993-141-30 ndc (product): 66993-141 ndc11 (package): 66993014130 rxcui: 1011736
ALISKIREN	ALISKIREN	Par Health USA, LLC	f3fd2503-25ef-4660-a29a-f62c491e28fb	2022-12-30	Boxed warning, Warnings, Adverse reactions	Exact identifier ndc (package): 49884-424-11 ndc (product): 49884-424 ndc11 (package): 49884042411 rxcui: 1011736

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 4 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
f3fd2503-25ef-4660-a29a-f62c491e28fb	aliskiren 150 MG Oral Tablet [PSN] · aliskiren 150 MG Oral Tablet [SCD] · aliskiren (as aliskiren fumarate) 150 MG Oral Tablet [SY]	3	29	These highlights do not include all the information needed to use ALISKIREN TABLETS safely and effectively. See full prescribing information for ALISKIREN TABLETS . ALISKIREN tablets , for oral use Initial U.S. Approval: 2007	20200924
41c0e5e0-eb26-4d9e-bcd2-d0f2cc8fc6db	aliskiren 150 MG Oral Tablet [PSN] · aliskiren 150 MG Oral Tablet [SCD] · aliskiren (as aliskiren fumarate) 150 MG Oral Tablet [SY]	3	18	These highlights do not include all the information needed to use Aliskiren safely and effectively. See full prescribing information for Aliskiren. Aliskiren tablets, for oral use Initial U.S. Approval: 2007	20230501
3dd61fa5-1620-4ebf-bbdb-ede29b92fce2	aliskiren 150 MG Oral Tablet [PSN] · aliskiren 150 MG Oral Tablet [SCD] · aliskiren (as aliskiren fumarate) 150 MG Oral Tablet [SY]	3	16	These highlights do not include all the information needed to use TEKTURNA safely and effectively. See full prescribing information for TEKTURNA. TEKTURNA ® (aliskiren) tablets, for oral use Initial U.S. Approval: 2007	20240307
4c222831-90af-4336-8bf6-5628ddf24326	aliskiren 150 MG Oral Tablet [PSN] · aliskiren 150 MG Oral Tablet [SCD] · aliskiren (as aliskiren fumarate) 150 MG Oral Tablet [SY]	3	2	These highlights do not include all the information needed to use TEKTURNA ® safely and effectively. See full prescribing information for TEKTURNA ® . Tekturna ® (aliskiren) tablets, for oral use Initial U.S. Approval: 200 7	20120113

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set ID	Title	Manufacturer	Effective
41c0e5e0-eb26-4d9e-bcd2-d0f2cc8fc6db	These highlights do not include all the information needed to use Aliskiren safely and effectively. See full prescribing information for Aliskiren. Aliskiren tablets, for oral use Initial U.S. Approval: 2007	Prasco Laboratories	20230501
f3fd2503-25ef-4660-a29a-f62c491e28fb	These highlights do not include all the information needed to use ALISKIREN TABLETS safely and effectively. See full prescribing information for ALISKIREN TABLETS . ALISKIREN tablets , for oral use Initial U.S. Approval: 2007	Par Health USA, LLC	20221230
f3fd2503-25ef-4660-a29a-f62c491e28fb	These highlights do not include all the information needed to use ALISKIREN TABLETS safely and effectively. See full prescribing information for ALISKIREN TABLETS . ALISKIREN tablets , for oral use Initial U.S. Approval: 2007	Endo USA, Inc.	20200924
02f2d79f-b896-44b7-a6ba-3ab28ddad0f2		National Council for Prescription Drug Programs	20120724
720b7811-4d0d-4f2e-b44f-3cf2f3d37434		National Council for Prescription Drug Programs	20120724
9b7a8fa4-3518-47b3-85bc-3c531bd1e352		National Council for Prescription Drug Programs	20120724
4c222831-90af-4336-8bf6-5628ddf24326	These highlights do not include all the information needed to use TEKTURNA ® safely and effectively. See full prescribing information for TEKTURNA ® . Tekturna ® (aliskiren) tablets, for oral use Initial U.S. Approval: 200 7	Physicians Total Care, Inc.	20120113

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	C09XA	Renin-inhibitors	ATC1-4		aliskiren
FDASPL	N0000175900	Renin Inhibitor	EPC	has_epc	aliskiren
FDASPL	N0000175899	Renin Inhibitors	MOA	has_moa	aliskiren
MEDRT	D000577	Amides	CHEM	has_ingredient	aliskiren
MEDRT	D005650	Fumarates	CHEM	has_ingredient	aliskiren
MEDRT	D013449	Sulfonamides	CHEM	ci_chemclass	aliskiren
MEDRT	D001002	Anuria	DISEASE	ci_with	aliskiren
MEDRT	D002675	Child, Preschool	DISEASE	ci_with	aliskiren
MEDRT	D003920	Diabetes Mellitus	DISEASE	ci_with	aliskiren
MEDRT	D006967	Hypersensitivity	DISEASE	ci_with	aliskiren
MEDRT	D006973	Hypertension	DISEASE	may_treat	aliskiren
MEDRT	N0000000181	Angiotensin-converting Enzyme Inhibitors	MOA	ci_moa	aliskiren
MEDRT	N0000000181	Angiotensin-converting Enzyme Inhibitors	MOA	has_moa	aliskiren
MEDRT	N0000175899	Renin Inhibitors	MOA	ci_moa	aliskiren
MEDRT	N0000175899	Renin Inhibitors	MOA	has_moa	aliskiren
MEDRT	N0000178477	Decreased Blood Pressure	PE	has_pe	aliskiren

Group, Type, Concept table
Group	Type	Concept	Source
BN	BN	Tekturna	rxnav_allrelated
DF	DF	Oral Tablet	rxnav_allrelated
DFG	DFG	Oral Product	rxnav_allrelated
DFG	DFG	Pill	rxnav_allrelated
IN	IN	aliskiren	rxnav_allrelated
SBD	SBD	aliskiren 150 MG Oral Tablet [Tekturna]	rxnav_allrelated
SBDC	SBDC	aliskiren 150 MG [Tekturna]	rxnav_allrelated
SBDF	SBDF	aliskiren Oral Tablet [Tekturna]	rxnav_allrelated
SBDG	SBDG	Tekturna Oral Product	rxnav_allrelated
SBDG	SBDG	Tekturna Pill	rxnav_allrelated
SCD	SCD	aliskiren 150 MG Oral Tablet	rxnav_allrelated
SCDC	SCDC	aliskiren 150 MG	rxnav_allrelated
SCDF	SCDF	aliskiren Oral Tablet	rxnav_allrelated
SCDG	SCDG	aliskiren Oral Product	rxnav_allrelated
SCDG	SCDG	aliskiren Pill	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	AVAILABLE_STRENGTH	150 MG
ATTRIBUTES	GENERAL_CARDINALITY	SINGLE
ATTRIBUTES	HUMAN_DRUG	US
ATTRIBUTES	RXNAV_HUMAN_DRUG	US
ATTRIBUTES	SCHEDULE	0
CODES	ANDA	ANDA206665
CODES	SNOMEDCT	783029009
CODES	VUID	4025956
CODES	VUID	4025957
NAMES	Prescribable Synonym	aliskiren 150 MG Oral Tablet
SOURCES	Source	Gold Standard Alchemy
SOURCES	Source	Metathesaurus FDA Structured Product Labels
SOURCES	Source	Micromedex RED BOOK
SOURCES	Source	Multum MediSource Lexicon
SOURCES	Source	National Drug Data File Plus Source Vocabulary
SOURCES	Source	US Edition of SNOMED_CT
SOURCES	Source	Veterans Health Administration National Drug File